Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FATYB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,093
Award facts
- Contract value 100% obligated
- $18,093.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,093.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for TYPHIM VI 25 MCG/0.5 ML syringes. The award was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, with performance to be executed in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order falls under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the federal military medical supply chain, maintaining a broad product portfolio that includes branded and generic prescription medications, biologics, vaccines, and medical consumables. The company has demonstrated substantial federal contracting activity with the Defense Logistics Agency's Medical Supply Chain division throughout 2025, with delivery orders ranging in value from under $100 to exceeding $115,000. The PPV-G GEN V contract under which this delivery order was issued features a $499.999 billion ceiling value with a completion date of December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting recurring medical supply needs across the Department of Defense's global healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FATYB?
SPE2DB26FATYB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FATYB worth?
The government has obligated $18,093 on SPE2DB26FATYB.
Is contract SPE2DB26FATYB an order under another contract?
Yes. SPE2DB26FATYB is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATYB competed?
The extent of competition for SPE2DB26FATYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award